Home › Hyperlipoproteinemia Type II › California
Hyperlipoproteinemia Type II clinical trials in California
4 studies for Hyperlipoproteinemia Type II are looking for participants at sites in California.
Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
- Clinical Study Center, Garden Grove
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Oct 23, 2026 · NCT06451770A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
- Clinical Study Center, Pomona
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Sep 2, 2026 · NCT06164730Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- UC San Francisco Medical Center, San Francisco
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Jul 24, 2026 · NCT06597006Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- UC San Francisco Medical Center, San Francisco
- UC San Francisco Medical Center, San Francisco
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated May 15, 2026 · NCT06597019From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.